scispace - formally typeset
S

Shalini Dogra

Researcher at Central Drug Research Institute

Publications -  26
Citations -  412

Shalini Dogra is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Metabotropic glutamate receptor & Medicine. The author has an hindex of 9, co-authored 19 publications receiving 236 citations. Previous affiliations of Shalini Dogra include Council of Scientific and Industrial Research & Vanderbilt University.

Papers
More filters
Journal ArticleDOI

Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation

TL;DR: For a prototypical GPCR, the human vasopressin receptor type 2 (V2R), βarr1 can form a stable complex associated via only the phosphorylated carboxyl terminus of the receptor that is functionally competent with respect to supporting receptor internalization and ERK MAPK activation.
Journal ArticleDOI

Biased agonism at kappa opioid receptors: Implication in pain and mood disorders.

TL;DR: Various lines of evidence are highlighted, which indicates different ligands of k receptor as "biased", and their potential implications in mood and pain disorders.
Journal ArticleDOI

A synthetic intrabody-based selective and generic inhibitor of GPCR endocytosis.

TL;DR: The data demonstrate the feasibility of selectively targeting βarr interactions using intrabodies and provide a novel framework for fine-tuning GPCR functions with potential therapeutic implications.
Journal ArticleDOI

Docosahexaenoic acid modulates brain-derived neurotrophic factor via GPR40 in the brain and alleviates diabesity-associated learning and memory deficits in mice.

TL;DR: Evidence is provided that DHA stimulation of GPR40 mediate some of DHA's beneficial effects in metabolic syndrome and identify G PR40 as a viable therapeutic target for the treatment of CNS-related comorbidities associated with diabesity.